Home / Repaglinide / Italy
IT ATC A10BX02 · updated 2 Nov 2026
Repaglinide shortage in Italy
Is there a Repaglinide shortage in Italy?
Yes. As of 2 Nov 2026, 2 Repaglinide products are reported short in Italy, the first since 30 Jun 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Spain, Czechia, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | REPAGLINIDE AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 30 Jun 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | REPAGLINIDE PENSA | TOWA PHARMACEUTICAL S.P.A. | 1 Aug 2026 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.